Voyager Therapeutics (VYGR) Enterprise Value (2014 - 2026)
Voyager Therapeutics (VYGR) posted Enterprise Value of -$141.5 million for Q1 2026, up 27.98% sequentially from -$196.4 million in Q4 2025, and up 40.06% YoY from -$101.0 million in Q1 2025.
Voyager Therapeutics (VYGR) Enterprise Value (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported Enterprise Value for 13 years, with the latest figure at -$141.5 million in Q1 2026.
- Quarterly Enterprise Value rose 40.06% year-over-year to -$141.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$141.5 million (up 40.06% YoY) and the FY2025 annual result came in at -$196.4 million, up 26.34% from the prior year.
- Enterprise Value advanced to -$141.5 million in Q1 2026 per VYGR's latest filing, from -$196.4 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$118.8 million in Q4 2022 and troughed at -$399.6 million in Q1 2024.
- A 5-year average of -$233.9 million and a median of -$230.9 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value slumped 94.26% in 2023, then jumped 41.89% in 2025.
- Over 5 years, Enterprise Value stood at -$118.8 million in 2022, then plunged by 94.26% to -$230.9 million in 2023, then fell by 15.51% to -$266.7 million in 2024, then climbed by 26.34% to -$196.4 million in 2025, then grew by 27.98% to -$141.5 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$141.5 million, -$196.4 million, and -$208.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.41 Bn | 130.56 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.41 Bn | 59.23 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 57.56 Bn | 52.43 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.06 Bn | 36.96 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.95 Bn | 27.65 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.48 Bn | 9.09 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.31 Bn | 26.15 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.04 Bn | 26.20 Bn | - | 2.12 Bn |
| 10 | Voyager Therapeutics | 202.23 Mn | 85.89 Mn | - | -116.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -116.34 Mn |
| Mar 31, 2026 | -141.48 Mn |
| Dec 31, 2025 | -196.45 Mn |
| Sep 30, 2025 | -208.93 Mn |
| Jun 30, 2025 | -215.59 Mn |
| Mar 31, 2025 | -236.02 Mn |
| Dec 31, 2024 | -266.68 Mn |
| Sep 30, 2024 | -345.36 Mn |
| Jun 30, 2024 | -371.02 Mn |
| Mar 31, 2024 | -399.57 Mn |
| Dec 31, 2023 | -230.88 Mn |
| Sep 30, 2023 | -252.94 Mn |
| Jun 30, 2023 | -272.75 Mn |
| Mar 31, 2023 | -273.31 Mn |
| Dec 31, 2022 | -118.85 Mn |
| Sep 30, 2022 | -131.64 Mn |
| Jun 30, 2022 | -148.06 Mn |
| Mar 31, 2022 | -166.83 Mn |
| Dec 31, 2021 | -132.54 Mn |
| Sep 30, 2021 | -121.50 Mn |